2[1]Connell JM,Davies E.The new biology of aldosterone[J].J Endocrinol,2005,186 (1):1-20.
3[2]Pitt B,Zannad F,Remme WJ,et al.The effects of spironnlactone on morbidity and mortality in patients with serve heart failure.Randomized Aldoctone Evaluation Study Investigator[J].N Engl J Med,1999,341 (10):709-717.
4[3]Pitt B,Remme WJ,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348 (14):1309-1321.
5[4]Sun Y,Zhang J,Lu L,et al.Aldosterone-induced inflammation in the rat heart:role of oxidative stress[J].Am J Pathol,2002,161 (5):1773-1781.
6[5]Rocha R,Rudolph AE,Frierdich GE,et al.Aldosterone-induces a vascular inflammatory phenotype in the rat heart[J].Am J Physiol Heart Circ Physiol,2002,283 (5):H1802-H1810.
7[6]Park YM,Park MY,Suh YL,et al.NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats[J].Biochem Biophys Res Commun,2004,313 (3):812-817.
8[7]Macdonald JE,Kennedy N,Struthers AD.Effects of spironolactone on endothelial function,vascular angiotesin converting enzyme activity,and other prognostic markers in patients with mild heart failure already taking optimal treatment[J].Heart,2004,90 (7),765-770.
9[8]Funder JW.Aldosterone,mineralocorticoid receptor and vascular inflammation[J].Mol Cell Endocrinol,2004,217(1-2):263-269.
10[9]Lee YS,Kim JA,Kim KL,et al.Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes[J].J Korean Med Sci,2004,19 (6):805-811.
